Inhibition of Insulin Secretion

Advances in Pharmacology

Volumn 52, Issue , 2005, Pages 173-192

  Young, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; ANTIDIABETIC AGENT; INSULIN;

ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; PANCREAS ISLET BETA CELL; REVIEW; SECRETION;

AMYLOID; ANIMALS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS;

EID: 33645222938     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)52009-X     Document Type: Review

References (104)

1. Adrian T.E., Bloom S.R., and Edwards A.V. Neuroendocrine responses to stimulation of the vagus nerves in bursts in conscious calves. J. Physiol. (Lond.) 344 (1983) 25-35
2. Ahren B. Effects of galanin and calcitonin gene-related peptide on insulin and glucagon secretion in man. Acta Endocrinol. (Copenh.) 123 (1990) 591-597
3. Ahren B., and Pettersson M. Calcitonin gene-related peptide (CGRP) and amylin and the endocrine pancreas. Int. J. Pancreatol. 6 (1990) 1-15
4. Ahren B., Oosterwijk C., Lips C.J., and Hoppener J.W. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice. Diabetologia 41 (1998) 1374-1380
5. Ar'Rajab A., and Ahren B. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats. Eur. J. Pharmacol. 192 (1991) 443-445
6. Barakat A., Skoglund G., Boissard C., Rosselin G., and Marie J.C. Calcitonin gene-related peptide and islet amyloid polypeptide stimulate insulin secretion in RINm5F cells through a common receptor coupled to a generation of cAMP. Biosci. Rep. 14 (1994) 1-13
7. Beglinger C., Koehler E., Born W., Fischer J.A., Keller U., Hanssen L.E., and Gyr K. Effect of calcitonin and calcitonin gene-related peptide on pancreatic functions in man. Gut 29 (1988) 243-248
8. Bendayan M. Pathway of insulin in pancreatic tissue on its release by the B-cell. Am. J. Physiol. 264 (1993) G187-G194
9. Bennet W.M., Beis C.S., Ghatei M.A., Byfield P.G.H., and Bloom S.R. Amylin tonally regulates arginine-stimulated insulin secretion in rats. Diabetologia 37 (1994) 436-438
10. Bloom S.R. Paracrine regulation of regulatory peptides. Biomed. Res. 15 (1994) 1-4
11. Bloom S.R., and Edwards A.V. The role of the parasympathetic system in the control of insulin release in the conscious calf. J. Physiol. (Lond.) 314 (1981) 37-46
12. Bloom S.R., and Edwards A.V. Characteristics of the neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious calf. J. Physiol. (Lond.) 346 (1984) 533-545
13. Bloom S.R., and Edwards A.V. Effects of certain metabolites on pancreatic endocrine responses to stimulation of the vagus nerves in conscious calves. J. Physiol. (Lond.) 362 (1985) 303-310
14. Bloom S.R., and Edwards A.V. The role of the sympathetic system in the control of insulin release in response to hyperglycaemia in conscious calves. J. Physiol. (Lond.) 362 (1985) 311-317
15. Bloom S.R., Edwards A.V., and Ghatei M.A. Neuroendocrine responses to stimulation of the splanchnic nerves in bursts in the conscious adrenalectomized calf. J. Physiol. (Lond.) 346 (1984) 519-531
16. Bretherton-Watt D., Gilbey S.G., Ghatei M.A., Beacham J., and Bloom S.R. Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man. Diabetologia 33 (1990) 115-117
17. Bretherton-Watt D., Ghatei M.A., Jamal H., Gilbey S.G., Jones P.M., and Bloom S.R. The physiology of calcitonin gene-related peptide in the islet compared with that of islet amyloid polypeptide (amylin). Ann. N Y Acad. Sci. 657 (1992) 299-312
18. Bretherton-Watt D., Gilbey S.G., Ghatei M.A., Beacham J., Macrae A.D., and Bloom S.R. Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man. J. Clin. Endocrinol. Metab. 74 (1992) 1032-1035
19. Broderick C.L., Brooke G.S., DiMarchi R.D., and Gold G. Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets. Biochem. Biophys. Res. Commun. 177 (1991) 932-938
20. Broderick C.L., and Gold G. Human and rat amylin have no effect on insulin secretion in isolated rat islets or in HIT cells. Diabetes 40 (1991) 233A
21. Cantalamessa L., Cantania A., Reschini E., and Peracchi M. Inhibitory effect of calcitonin on growth hormone and insulin secretion in man. Metabolism 27 (1978) 987-992
22. Chuang L.M., Wu H.P., Jou T.S., Tai T.Y., and Lin B.J.I. Inhibitory effect of islet amyloid polypeptide on glucose-induced proinsulin biosynthesis in rat insulinoma cells. Pancreas 7 (1992) 472-476
23. Dégano P., Peiro E., Silvestre R.A., Coma I., Salas M., and Marco J. Insulin responses of the amylin-infused rat pancreas to glucose vasoactive intestinal polypeptide and arginine. Diabetologia 34 (1991) A42
24. Dégano P., Salas M., Peiro E., Silvestre R.A., and Marco J. On the mechanism of the inhibitory effect of amylin on insulin secretion: Study in the perfused rat pancreas. Diabetologia 35 (1992) A115
25. Dégano P., Silvestre R.A., Salas M., Peiró E., and Marco J. Amylin inhibits glucose-induced insulin secretion in a dose-dependent manner. Study in the perfused rat pancreas. Regul. Pept. 43 (1993) 91-96
26. Edwards A.V., and Bloom S.R. Pancreatic endocrine responses to substance P and calcitonin gene-related peptide in conscious calves. Am. J. Physiol. 30 (1994) E847-E852
27. Fehmann H.C., Weber V., Göke R., Göke B., Eissele R., and Arnold R. Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem. Biophys. Res. Commun. 167 (1990) 1102-1108
28. Fürnsinn C., Leuvenink H., Roden M., Nowotny P., and Waldhäusl W. Inhibition of glucose induced insulin secretion by amylin in rats in vivo. Diabetologia 35 (1992) A29
29. Fürnsinn C., Leuvenink H., Roden M., Nowotny P., Schneider B., Rohac M., Pieber T., Clodi M., and Waldhausl W. Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am. J. Physiol. 267 (1994) E300-E305
30. Gebre-Medhin S., Mulder H., Pekny M., Westermark G., Tornell J., Westermark P., Sundler F., Ahren B., and Betsholtz C. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem. Biophys. Res. Commun. 250 (1998) 271-277
31. Gedulin B., Rink T.J., Larson E., and Young A.A. Effects of amylin infusion on plasma glucose and insulin during i.v. glucose tolerance test in anesthetized rats (1992)
32. Gedulin B., Larson E., Provost S., and Koda J. The selective amylin antagonist, AC187, enhances the insulin response during intravenous glucose tolerance tests in anesthetized rats. Diabetes 42 suppl. 1 (1993) 229A
33. Ghatei M.A., Datta H.K., Zaidi M., Bretherton-Watt D., Wimalawansa S.J., Mac Intyre I., and Bloom S.R. Amylin and amylin-amide lack an acute effect on blood glucose and insulin. J. Endocrinol. 124 (1990) R9-R11
34. Gilbey S.G., Bretherton-Watt D., Beacham J., Ghatei M.A., and Bloom S.R. High dose amylin in man: Unexpected failure to affect intravenous glucose tolerance. BDA Diab. Med. 6 (1989) 5A
35. Göke R., McGregor G.P., and Göke B. Amylin alters biological effects of GLP-1 in the ß-cell. Digestion 54 (1993) 355-356
36. Göke R., McGregor G.P., and Göke B. Amylin alters the biological action of the incretin hormone GLP-1 (7-36)amide. Life Sci. 53 (1993) 1367-1372
37. Gold G., Dimarchi R.D., Broderick C.L., Bue J.M., Brooke G.S., and Yen T.T. Human amylin has no effect on either rate of insulin release or concentration of glucose in rodents. Diabetes 39 (1990) 142A
38. Inoue K., Hiramatsu S., Hisatomi A., Umeda F., and Nawata H. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas. Horm. Metab. Res. 25 (1993) 135-137
39. Ishizuka J., Singh P., Greeley Jr. G.H., Townsend Jr. C.M., Cooper C.W., Tatemoto K., and Thompson J.C. A comparison of the insulinotropic and the insulin-inhibitory actions of gut peptides on newborn and adult rat islet cells. Pancreas 3 (1988) 77-82
40. Johnson K.H., O'Brien T.D., Jordan K., Betsholtz C., and Westermark P. The putative hormone islet amyloid polypeptide (IAPP) induces impaired glucose tolerance in cats. Biochem. Biophys. Res. Commun. 167 (1990) 507-513
41. Jonderko K., Jonderko G., and Golab T. Effect of calcitonin on gastric emptying and on serum insulin and gastrin concentrations after ingestion of a mixed solid-liquid meal in humans. J. Clin. Gastroenterol. 12 (1990) 22-28
42. Kogire M., Ishizuka J., Thompson J.C., and Greeley G.H. Inhibitory action of islet amyloid polypeptide and calcitonin gene-related peptide on release of insulin from the isolated perfused rat pancreas. Pancreas 6 (1991) 459-463
43. Kulkarni R.N., Smith D.M., Ghatei M.A., Jones P.M., and Bloom S.R. Investigation of the effects of antisense oligodeoxynucleotides to islet amyloid polypeptide mRNA on insulin release, content and expression. J. Endocrinol. 151 (1996) 341-348
44. Leaming R., Johnson A., Hook G., Hanley R., and Baron A. Amylin modulates insulin secretion in humans. Studies with an amylin antagonist. Diabetologia 38 (1995) A113
45. Lehman-deGaeta L.S., Willis A.C., Young A.A., Foot E.A., Albrecht E., Leighton B., Rink T.J., and Cooper G.J.S. Variability of chemically synthesized human amylin. Diabetes 40 (1991) 236A
46. Lewis C.E., Clark A., Ashcroft S.J., Cooper G.J.S., and Morris J.F. Calcitonin gene-related peptide and somatostatin inhibit insulin release from individual rat B cells. Mol. Cell Endocrinol. 57 (1988) 41-49
47. Lorenzo A., and Yankner B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91 (1994) 12243-12247
48. Lorenzo A., Razzaboni B., Weir G.C., and Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368 (1994) 756-760
49. Lunetta M., Infantone E., Spanti D., and Mughini L. Effects of synthetic salmon calcitonin administration on gastrin, immunoreactive insulin and growth hormone release after protein meal in uremic patients. J. Endocrinol. Invest. 4 (1981) 185-188
50. Marco J., and Silvestre R. Effect of amylin on islet cell secretion. Exp. Clin. Endocrinol. Diabet. 105 (1997) 68
51. Marco J., Peiro E., Dégano P., Miralles P., and Silvestre R.E. Amylin inhibits insulin secretion in the perfused rat pancreas. Diabetes 39 (1990) 136A
52. Mather K.J., Paradisi G., Leaming R., Hook G., Steinberg H.O., Fineberg N., Hanley R., and Baron A.D. Role of amylin in insulin secretion and action in humans: Antagonist studies across the spectrum of insulin sensitivity. Diabet. Metab. Res. Rev. 18 (2002) 118-126
53. May P.C., Boggs L.N., and Fuson K.S. Neurotoxicity of human amylin in rat primary hippocampal cultures-similarity to Alzheimer's disease amyloid-beta neurotoxicity. J. Neurochem. 61 (1993) 2330-2333
54. Mulder H., Ahren B., Karlsson S., and Sundler F. Adrenomedullin: Localization in the gastrointestinal tract and effects on insulin secretion. Regul. Pept. 62 (1996) 107-112
55. Murakami M., Suzuki S., Sato Y., Shintami S., Abe S., Suzuki K., Ishuzuka J., and Toyota T. Effects of amylin on insulin secretion from RIN m5F cells. Diabetes 39 (1990) 266A
56. Nagamatsu S., Carroll R., and Steiner D.F. IAPP effects on pancreatic beta cell function in normal rat islets and BTC3 cell line. Diabetes 39 (1990) 67A
57. Nagamatsu S., Carroll R.J., Grodsky G.M., and Steiner D.F. Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes 39 (1990) 871-874
58. Nagamatsu S., Nishi M., and Steiner D.F. Effects of islet amyloid polypeptide (IAPP) on insulin biosynthesis or secretion in rat islets and mouse beta TC3 cells. Biosynthesis of IAPP in mouse beta TC3 cells. Diabet. Res. Clin. Pract. 15 (1992) 49-55
59. O'Brien T.D., Westermark P., and Johnson K.H. Islet amyloid polypeptide (IAPP) does not inhibit glucose-stimulated insulin secretion from isolated perfused rat pancreas. Biochem. Biophys. Res. Commun. 170 (1990) 1223-1228
60. O'Harte F.P.M., Abdel Wahab Y.H.A., Conlon J.M., and Flatt P.R. Glycated IAPP shows a reduced inhibitory action on insulin secretion. Biochem. Soc. Trans. 26 (1998) S6
61. Ohsawa H., Kanatsuka A., Yamaguchi T., Makino H., and Yoshida S. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem. Biophys. Res. Commun. 160 (1989) 961-967
62. Panagiotidis G., Salehi A.A., Westermark P., and Lundquist I. Homologous islet amyloid polypeptide: Effects on plasma levels of glucagon, insulin and glucose in the mouse. Diabet. Res. Clin. Pract. 18 (1992) 167-171
63. Peiró E., Dégano P., Silvestre R.A., and Marco J. Inhibition of insulin release by amylin is not mediated by changes in somatostatin output. Life Sci. 49 (1991) 761-765
64. Petralito A., Lunetta M., Liuzzo A., Fiore C.E., and Heynen G. Effects of salmon calcitonin on blood glucose and insulin levels under basal conditions after intravenous glucose load. J. Endocrinol. Invest. 2 (1979) 209-211
65. Pettersson M., and Ahren B. Insulin and glucagon secretion in rats: Effects of calcitonin gene-related peptide. Regul. Pept. 23 (1988) 37-50
66. Pettersson M., and Ahren B. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats. Acta Physiol. Scand. 138 (1990) 389-394
67. Pettersson M., Lundquist I., and Ahren B. Neuropeptide Y and calcitonin gene-related peptide: Effects on glucagon and insulin secretion in the mouse. Endocr. Res. 13 (1987) 407-417
68. Riediger T., Rauch M., Jurat G., and Schmid H.A. Central nervous targets for pancreatic amylin. Pflugers Arch. 437 (1999) R142
69. Riediger T., Schmid H.A., Lutz T.A., and Simon E. Amylin and glucose co-activate area postrema neurons of the rat. Neurosci. Lett. 328 (2002) 121-124
70. Roberts A., Leighton B., Todd J.A., Cockburn D., Schofield P.N., Sutton R., Holt S., Boyd Y., Day A.J., Foot E.A., Willis A.C., Reid K.B.M., and Cooper G.J.S. Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc. Natl. Acad. Sci. USA 86 (1989) 9662-9666
71. Rodriguez-Gallardo J., Silvestre R.A., Salas M., and Marco J. Rat amylin versus human amylin: Effects on insulin secretion in the perfused rat pancreas. Med. Sci. Res. 23 (1995) 569-570
72. Salas M., Silvestre R.A., Gutiérrez E., Fontels T., Garcia-Hermida O., and Marco J. Potentiation of the insulin response to glucose by an amylin antagonist (8-32 salmon calcitonin). Diabetologia 37 (1994) A116
73. Salas M., Silvestre R.A., Garcia-Hermida O., Fontela T., Rodriguez-Gallardo J., and Marco J. Inhibitory effect of amylin (islet amyloid polypeptide) on insulin response to non-glucose stimuli: Study in perfused rat pancreas. Diabet. Metab. 21 (1995) 269-273
74. Sandler S., and Stridsberg M. Chronic exposure of cultured rat pancreatic islets to elevated concentrations of islet amyloid polypeptide (IAPP) causes a decrease in islet DNA content and medium insulin accumulation. Regul. Pept. 53 (1994) 103-109
75. Sgambato S., Passariello N., Paolisso G., Marano A., Buoninconti R., and Tesauro P. Effect of human calcitonin (hCT) on glucose- and arginine-stimulated insulin secretion. Acta Diabetol. Lat. 23 (1986) 13-22
76. Silvestre R.A., Peiro E., Dégano P., Iglesias A., Miralles P., and Marco J. Rat amylin inhibits insulin release without affecting glucagon and somatostatin output in the rat pancreas. Diabetologia 33 (1990) A40
77. Silvestre R.A., Peiró E., Dégano P., Miralles P., and Marco J. Inhibitory effect of rat amylin on the insulin responses to glucose and arginine in the perfused rat pancreas. Regul. Pept. 31 (1990) 23-31
78. Silvestre R.A., Dégano P., Salas M., Peiro E., and Marco J. Calcitonin gene-related peptide (CGRP) and amylin inhibition of insulin release is reversed by the 8-37 CGRP fragment. Diabetologia 35 (1992) A29
79. Silvestre R.A., Salas M., Dégaño P., Fontela T., García-Hermida O., and Marco J. Prevention of the inhibitory effect of amylin on GIP-induced insulin release by Pertussis toxin pretreatment. Diabetologia 36 (1993) A136
80. Silvestre R.A., Salas M., Degano P., Peiro E., and Marco J. Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP. Biochem. Pharmacol. 45 (1993) 2343-2347
81. Silvestre R.A., Salas M., Garcia-Hermida O., Fontela T., Degano P., and Marco J. Amylin (islet amyloid polypeptide) inhibition of insulin release in the perfused rat pancreas: Implication of the adenylate cyclase/cAMP system. Regul. Pept. 50 (1994) 193-199
82. Silvestre R.A., Salas M., Rodriguez-Gallardo J., Garcia-Hermida O., Fontela T., and Marco J. Effect of (8-32). salmon calcitonin, an amylin antagonist, on insulin, glucagon and somatostatin release: Study in the perfused pancreas of the rat. Br. J. Pharmacol. 117 (1996) 347-350
83. Silvestre R.A., Rodríguez-Gallardo J., Gutiérrez E., and Marco J. Influence of glucose concentration on the inhibitory effect of amylin on insulin secretion: Study in the perfused rat pancreas. Regul. Pept. 68 (1997) 31-35
84. Silvestre R.A., Rodriguez-Gallardo J., Jodka C., Parkes D.G., Pittner R.A., Young A.A., and Marco J. Selective amylin inhibition of the glucagon response to arginine is extrinsic to the pancreas. Am. J. Physiol. 280 (2001) E443-E449
85. Smith D.M., and Bloom S.R. Paracrine/autocrine control of the islet and the amylin family. Biochem. Soc. Trans. 23 (1995) 336-340
86. Stevenson J.C., Adrian T.E., Christofides N.D., and Bloom S.R. Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin. Endocrinol. (Oxf.) 22 (1985) 655-660
87. Stridsberg M., Wilander E., Öberg K., Lundqvist G., and Eriksson B. Islet amyloid polypeptide-producing pancreatic islet cell tumor. Scand. J. Gastroenterol. 27 (1992) 381-387
88. Stridsberg M., Berne C., Sandler S., Wilander E., and Oberg K. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule. Diabetologia 36 (1993) 843-849
89. Suzuki S., Murakami M., Abe S., Satoh Y., Shintani S., Ishizuka J., Suzuki K., Thompson J.C., and Toyota T. The effects of amylin on insulin secretion from Rin m5F cells and glycogen synthesis and lipogenesis in rat primary cultured hepatocytes. Diabet. Res. Clin. Pract. 15 (1992) 77-84
90. Tedstone A.E., Nezzer T., Hughes S.J., Clark A., and Matthews D.R. The effects of islet amyloid peptide and calcitonin gene-related peptide on insulin secretion in anaesthetised rats and from isolated rat islets. BDA Diabet. Med. 6 (1989) A38
91. Tedstone A.E., Nezzer T., Hughes S.J., Clark A., and Matthews D.R. The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro. Biosci. Rep. 10 (1990) 339-345
92. Vine W., Beaumont K., Gedulin B., Pittner R., Moore C.X., Rink T.J., and Young A.A. Comparison of the in vitro and in vivo pharmacology of adrenomedullin, calcitonin gene-related peptide and amylin in rats. Eur. J. Pharmacol. 314 (1996) 115-121
93. Wagoner P.K., Dukes I.D., and Worley III J.F. Amylin inhibition of glucose-induced changes in electrical activity, intracellular calcium and insulin release in mouse beta-cells. Diabetes 41 (1992) 103A
94. Wagoner P.K., Chen C., Worley J.F., Dukes I.D., and Oxford G.S. Amylin modulates ß-cell glucose sensing via effects on stimulus-secretion coupling. Proc. Natl. Acad. Sci. USA 90 (1993) 9145-9149
95. Wang F., Westermark G., Gasslander T., and Permert J. Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets. Regul. Pept. 72 (1997) 61-67
96. Wang M.W., Young A.A., Rink T.J., and Cooper G.J.S. 8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo. FEBS Lett. 291 (1991) 195-198
97. Wang Z.-L., Bennet W.M., Ghatei M.A., Byfield P.G.H., Smith D.M., and Bloom S.R. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42 (1993) 330-335
98. Young A.A., Carlo P., Rink T.J., and Wang M.-W. 8-37hCGRP, an amylin receptor antagonist, enhances the insulin response and perturbs the glucose response to infused arginine in anesthetized rats. Mol. Cell Endocrinol. 84 (1992) R1-R5
99. Young A.A., Gedulin B., Wolfe-Lopez D., Greene H.E., Rink T.J., and Cooper G.J.S. Amylin and insulin in rat soleus muscle: Dose responses for cosecreted noncompetitive antagonists. Am. J. Physiol. 263 (1992) E274-E281
100. Young A.A., Gedulin B., Larson E., and Rink T.J. Evidence from studies using a specific blocker for a metabolic effect of endogenous amylin in vivo. Diabetologia 36 suppl. 1 (1993) A136
101. Young A.A., Gedulin B., Gaeta L.S.L., Prickett K.S., Beaumont K., Larson E., and Rink T.J. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat-Evidence for a metabolic role of endogenous amylin. FEBS Lett. 343 (1994) 237-241
102. Young A.A., Wang M.W., Gedulin B., Rink T.J., Pittner R., and Beaumont K. Diabetogenic effects of salmon calcitonin are attributable to amylin-like activity. Metabolism 44 (1995) 1581-1589
103. Young A.A., Vine W., Gedulin B.R., Pittner R., Janes S., Gaeta L.S.L., Percy A., Moore C.X., Koda J.E., Rink T.J., and Beaumont K. Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin. Drug Dev. Res. 37 (1996) 231-248
104. Young A.A., Jodka C., Hoyt J., and Gedulin B. Involvement of the area postrema in nutrient-stimulated insulin secretion in rats. Diabetes 53 suppl. 1 (2004) A324-A325 (abstract 1344-P).